TMAs facilitate the ICs expression on tumor cells or produce IL-10, TGF-β, Arg-1, and IDO to impede T cell function (Arlauckas et al., 2018; Xiang et al., 2021; Kumari and Choi, 2022). The gene discussed is TGFB1; the disease is neoplasm.